Dr. Frank Pun, Associate Director (Project & Operations) at Insilico Medicine, describes his experience publishing a research paper that he co-authored, entitled, “Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine” with Aging (Aging-US).
Hi, I’m Frank Pun, Associate Director, Application Science Lead of Insilico Medicine.
I published a paper in the journal of Aging that we use PandaOmics and AI power discovery engine to identify dual purpose targets that are implicated in aging and age-associated diseases.
We would like to thank the reviewers for their timely response. Their comments were very constructive, which helped us further improve our paper. It was a very nice experience. We like to continue to publish there.
Click here to read the full study published by Aging (Aging-US).
Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research and other topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.
For media inquiries, please contact [email protected].